Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My take as to why we have such a high short position.
Our technology and process using a bacteria like listeria is not only non conventional but rather perceived as being dangerous.Afer all listeria laden blood is septecemia and leads to mortality and morbidity.
Am holding 50k shares not because I wanted to but got in at 16 and have been averaging down this past year.
Let's deal with the elephant in the room
What are our chances of getting eu and FDA approval next year ?
Aduro has their own combo testing with Merck?
Why do we have a manufacturing plant with no drug approval?
Why are there people posting about great combo results to come without a clue of proof?
How can we be sitting on the cure for cancer with such low volume?
Many questions need to be answered and management is pretty much silent.
So the investors talk about buying opportunities when we are sliding downward with no bad news.
And each conference brings us the same buyout or great news coming on combo results.
I know the stock market can be irrational and if it wasnt my own money I wouldn't even be concerned!
We are in a stall pattern.
Low volume no news gravitational pull.
As stockholders with no information we are a blind lot reduced to cheer leading and hopes of going from conference to conference waiting for a deal or at least some scientific data.
The cycle is repeating and getting old!
JB THANKS FOR THE USEFUL POST
HOPE DEALS COME SOONER THAN LATTER
So we are post SITC conference and no new data.
No new deals or partnerships...
We know they had a party but it wasnt to celebrate success.
Management enriched themselves by awarding themselves a ton of options at a low price.
And the beat goes on.....
hi Deckheight;
I dont speak for FBG but he wasnt accusing management of malfeasance or criminal activity.He was just stating that the stock price doesnt seem to be a concern to management.He also has a ton of stock and has the right to speak his mind with the stock price in the toilet.
Hey Deckheight;
FBG speaks for many of us...
We will never get value as long as Dan keeps diluting.
not believable why would astra come in at 13 when the present stock price is 8?
Adro didnt drop when we had our hold!
Biotech CEOs are taught to raise money when they can, not when they need it. What's astonishing about this Puma deal is Auerbach claimed the company didn't need money, and then went out and rammed through a stock sale when the market was telling him, clearly, that it wasn't interested.
Here's what Auerbach told investor clients of JPMorgan on a Sept. 30 conference call arranged by the investment bank.
So, our interest obviously is in doing non-dilutive types of situations, our interest of doing something dilutive is not high. We would much rather opt for something non-dilutive and we have a lot of discussions that have been ongoing. So we have a decent degree of confidence that there is no reason to need to raise money any time before launch.
After which his stock went down 20%
We need to stop the predicted dilution
Its Dans charge to add value to the stock price.
He does not do that by handing out shares to new hires nor present offering of shares at discounted rates.Time to put in someone who can build strength into the share price.
fbg;
You have lots of skin in the game as i do so your posts are visceral as my feelings.
Adro has the benefit and support of J J...
I am reading these posts and they remind me of the boxer in the ring getting his ass kicked shaking his head no and smiling as he takes a beating.The fact of the matter is most of us longs dont care about potential but rather stock price.And if the science is sound and curative then our problem is management.....Each day is becoming a down day from 5-10% if you are long it hurts.
Blue
You are right about this stock not holding any gain.
The pattern persists no matter what deals or positive results we have.
Blue like me you have ADXS psychosis.
That's the great expectations of this biotech to rise when it seems to disappoint 75% of the time.
Who would expect Amgen as a partner two years ago.
Keep the faith brother we will blow those shorts out of the water on out next combo deal.
Has the issue of dilution been brought up at any of the stock holder meetings?
Why do the tuts tolerate it?
Blue
Petit wouldn't be presenting the findings himself if the results were disappointing or inferior.
Once those results are released the horse will have left the barn!
Jump in now and bath yourselve in the riches of Adxs.
Like J/E said the life of a stock is dynamic and we have had a sea change with the Amgen partnership.
With Astra Merck and Amgen all in the pool we are looking good!
As well as Amgen fidelity broadfin and adage owning 50% of the stock.
Thanks Dawson for the post of j/e rebuttal
I think all of us longs needed that
We also can use a message from j/e now that Amgen is aboard
Any idea when we start getting the combo results?
Thanks easy for your insights.
Would like to gain some perspectives from someone who knows about our studies going forward.That is the dd I am looking for.Read j/e posts and convinced me to get in.Now a year latter the sp doesn't reflect the potential.
Give me specifics!
We need to obtain the most recent combo results or indications of where are studies are going rather than merely tweets or speculation.
Has anyone asked Dan about the huge short position and the performance of the stock price.
In any stock holder meeting that would be the elephant in the room.
We are sitting in a fragile biotech sector at this time.
When will we see results in our ongoing studies?
Here is the main question to focus on.
Are we sitting on a cure for cancer?
If we are every dip in the stock price is simply an artifact.
If we aren't and the science doesn't pan out we are just another biotech fizzle.
That's why I keep reaching out for someone on this board to give us an insight of how our studies are progressing.
As for Dan it's obvious the sp is of little concern presently for Dan and companies like adage and broadfin are hanging in there
With Governor Christy coming to the opening of the new building our donut expense is going to soar
I would like to think we are undervalued that's why all of us wait till the next investment conference or the next institution to make a big bet on Adxs or the next news release or phase 1,2,3 approvals.
But like Pavlos dog it's hard to look at the ticker and see the sp down so often!
James I admire your 7 year perseverance
We are trading 33% down from our intra day high only a couple of weeks after announcing a huge deal with Amgen.I am sitting on many shares of Adxs just seems like the stock price doesn't reflect the companies potential and am questioning why
Fact is we are holding a stock with the ability to cure cancer but continues to decay and go down daily.
The stocks action does not reflect the fact that the company is sitting on a solution for cancer.
I like cheerleaders but only when they have Pom poms in their hands and collectively shake their asses
I support your position FBG...
Dan has the recent announcement that the largest biotech Amgen is partnering with us in a sweet deal.The stock begins to run and gets cold water thrown on it by another stock offering....
The timing was poor and dubious and resulted in the stock retracing nearly 70% of its gains from the announcement..We need someone at the helm of the company who is much more sensitive the the stockholder value...
Dans charge is to shepard the stock price to levels higher than the investors bought in at.The company's success is reflected in the stock price.Without knowing what is happening in the studies and behind the scene in regards to partnership we are only privy to the shadows on the wall and what our wildest dreams of triple digit price.
It is at Mt Sinai medical school and hospital in nyc which is named after Ichan were some of Adxs work is being done.
So there are multiple connections here.
Sure hope so!
Anyone out there have an insight to our studies?
We were at 65%
then Broadfin doubled their position and the new offering of 3 million shares to the unidentified fund brings tute ownership to close to 80%
Broadfin added 5%
Amgen bought 10%
New investor health care investors 10%
Approximately 80% tutes ownership
Hang tight we will be soaring soon with a squeeze
Would like those shares to be scooped up by the baker bros
Not happy about these 2 directors dumping 55,000 shares just as the stock was gaining some traction
ERMAN RICHARD J
DIR
S
$520,755
33,761
8/8/16
8/9/16
$15.21
$15.67
50,669
-40.0
D
---
8/10/16 - 7:31:04 pm
2
1w1100%-8%2
SIDRANSKY DAVID
DIR
S
$342,348
22,808
8/8/16
8/9/16
---
$14.85
80,355
-22.1
D
---
8/10/16 - 7:30:23 pm
The Amgen deal gave us cred and was totally unexpected.
Other big time investors will now start sniffing around.
Interesting that Amgen would have made its 25 million back by the share price appreciation when the stock hit 16.